Abstract #2724

Amide proton transfer (APT) imaging of breast cancer at 3T MRI: a pilot study

Natsuko Onishi¹, Masako Kataoka¹, Shotaro Kanao¹, Mami Iima¹, Makiko Kawai¹, Akane Ohashi¹, Katsutoshi Murata², Benjamin Schmitt³, and Kaori Togashi¹

¹Dept of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan, ²Research & Collaboration Dpt., Siemens Japan K.K., Tokyo, Japan, ³Healthcare Sector, Siemens Ltd, Melbourne, Australia

Amide proton transfer (APT) imaging is the representative endogenous chemical exchange saturation transfer (CEST) imaging that has been applied to some clinical cancer studies. However, little is known about the clinical usefulness of APT imaging in breast cancer. In this study, 3T MRI studies including APT imaging were performed for 24 breast cancer lesions, and the possible utility of APT imaging in evaluating biochemical information induced by breast cancer was demonstrated. APT CEST imaging is a potentially useful MRI technique for breast cancer.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.